Petrovic G, Ristic V, Vrbaski S, Ristic M, Suzic S
Institute for Medical Research, Belgrade, Serbia.
Physiol Res. 1993;42(1):45-7.
The effect of chronic hydrocortisone administration (0.5 mg/kg) on the liver and plasma lipid content was assessed in Wistar rats. It was found after that the liver cholesterol content was significantly increased 6 months of hydrocortisone treatment. At the same time, the distribution of liver phospholipid fractions was altered. The fatty acid composition of liver lipids showed a significant increase of 22:6 n-3. Decreased levels of cholesterol and LDL-cholesterol were found in the plasma of the hydrocortisone-treated rats.
在Wistar大鼠中评估了长期给予氢化可的松(0.5毫克/千克)对肝脏和血浆脂质含量的影响。发现氢化可的松治疗6个月后,肝脏胆固醇含量显著增加。同时,肝脏磷脂组分的分布发生了改变。肝脏脂质的脂肪酸组成显示22:6 n-3显著增加。在接受氢化可的松治疗的大鼠血浆中发现胆固醇和低密度脂蛋白胆固醇水平降低。